Substance / Medication

Bishydroxycoumarin

Overview

Active Ingredient
dicumarol
RxNorm CUI
1598

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

30 trials linked to this intervention

30
Total Trials
9
Recruiting
5
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Safety and Efficacy of Factor Xa Inhibitors in Atrial Fibrillation Patients on Dialysis: Evidence from Four Randomized Controlled Trials.
Kaisaier Wulamiding, Chen Yili, Lip Gregory Y H et al. · Thromb Haemost · 2026
PMID: 39993439Meta-Analysis
Cabozantinib and thromboembolism in patients with cancer: a systematic review, meta-analysis, and retrospective study.
Eswaran Harish, Kasthuri Rohan R, Bendapudi Pavan K et al. · Blood Adv · 2026
PMID: 41061198Meta-AnalysisFull text (PMC)
Factor XI as a new target for prevention of thromboembolism in cardiovascular disease: a meta-analysis of randomized controlled trials.
Ali Ahmed E, Awad Mohamed K, Ali Karim et al. · J Thromb Thrombolysis · 2025
PMID: 38762711Meta-Analysis
Bioinformatics Analysis Reveals HIST1H2BH as a Novel Diagnostic Biomarker for Atrial Fibrillation-Related Cardiogenic Thromboembolic Stroke.
Jiang Wenbing, Jiang Lelin, Zhao Xiaoli et al. · Mol Biotechnol · 2025
PMID: 38825608Meta-Analysis
Left atrial appendage occlusion devices vs direct oral anticoagulants for atrial fibrillation: An updated systematic review and meta-analysis.
Fernandes Julia M, Pinheiro Rafael P S, Serpa Frans et al. · Curr Probl Cardiol · 2025
PMID: 39395644Meta-Analysis
Major clinical outcomes in symptomatic vs. asymptomatic atrial fibrillation: a meta-analysis.
Karakasis Paschalis, Pamporis Konstantinos, Siontis Konstantinos C et al. · Eur Heart J · 2025
PMID: 39428997Meta-Analysis
Perioperative direct oral anticoagulant management during cardiac implantable electronic device surgery: an updated systematic review and meta-analysis.
Ezenna Chidubem, Pereira Vinicius, Abozenah Mohammed et al. · J Interv Card Electrophysiol · 2025
PMID: 39546144Meta-Analysis
Warfarin and Aspirin Versus Warfarin Alone in Patients With HeartMate 3 Left Ventricular Assist Device: A Systematic Review and Meta-Analysis.
Viana Patricia, Lopes Lucca Moreira, Cabral Thamiris Dias Delfino et al. · Pacing Clin Electrophysiol · 2025
PMID: 39565678Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Dicoumarol (substance)
SNOMED CT
79209008
UMLS CUI
C0005640
RxNorm CUI
1598

Clinical Data

This intervention maps to 3 entities in the Healos knowledge graph.

3
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
30
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.

Bishydroxycoumarin — Conditions, Biomarkers & Specialists | Healos | Healos